Association between two genetic polymorphisms of the renin-angiotensin- aldosterone system and diabetic nephropathy: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 1293-1303

  Ding, Wei ^a   Wang, Furu ^b   Fang, Qiaoqiao ^c   Zhang, Minmin ^a   Chen, Jing ^a   Gu, Yong ^a  

^a FUDAN UNIVERSITY   (China)

^b JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

AGT M235T; AGTR1 A1166C; Diabetic nephropathy; Genetic epidemiology; Polymorphisms; RAAS

Indexed keywords

AGTR1 GENE; ANGIOTENSINOGEN GENE; ARTICLE; CASE CONTROL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ETHNICITY; GENE; GENETIC ANALYSIS; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; META ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTEMATIC REVIEW; ASIAN; CAUCASIAN; COMPARATIVE STUDY; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETICS; INHERITANCE; REGRESSION ANALYSIS; RISK; RISK FACTOR;

AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN;

ANGIOTENSINOGEN; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; HUMANS; INHERITANCE PATTERNS; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; REGRESSION ANALYSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 84860323096     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0862-7     Document Type: Article

References (52)

1. Schmidt S, Ritz E (1997) Genetics of the renin-angiotensin system and renal disease: a progress report. Curr Opin Nephrol Hypertens 6:146-151 (Pubitemid 27211776)
2. Burns KD (2000) Angiotensin II and its receptors in the diabetic kidney. Am J Kidney Dis 36:449-467
3. Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52:11-34 (Pubitemid 30127593)
4. Rahimi Z et al (2011) The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep 38:2117-2123. doi:10.1007/s11033-010-0338-1
5. Gumprecht J et al (2000) Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-Stage Renal Disease Study Group. Kidney Int 58:513-519. doi:10.1046/j.1523-1755.2000. 00197.x (Pubitemid 30620000)
6. Lovati E et al (2001) Genetic polymorphisms of the renin-angiotensin- aldosterone system in end-stage renal disease. Kidney Int 60:46-54. doi:10.1046/j.1523-1755.2001.00769.x (Pubitemid 32587538)
7. Wang WY, Zee RY, Morris BJ (1997) Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clin Genet 51:31-34 (Pubitemid 27116896)
8. Jeunemaitre X et al (1992) Molecular basis of human hypertension: role of angiotensinogen. Cell 71:169-180. doi:10.1016/00 92-8674(92)90275-H
9. Caulfield M et al (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633 (Pubitemid 24166862)
10. Lindholm LH et al (2002) Cardiovascular morbidity and mortality in patients with diabetes in the Losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359:1004-1010. doi:10.1016/S0140-6736(02)08090-X (Pubitemid 34286537)
11. Fogarty DG et al (1996) A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 45: 1204-1208 (Pubitemid 26296320)
12. Crisan D, Carr J (2000) Angiotensin I-converting enzyme: genotype and disease associations. J Mol Diagn 2:105-115
13. Doria A et al (1997) Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 40:1293-1299. doi:10.1007/s 001250050823 (Pubitemid 27469669)
14. Miller JA, Thai K, Scholey JW (2000) Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes. Diabetes 49(9):1585-1589. doi:10.2337/diabetes.49.9.1585
15. Gallego PH et al (2008) Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. J Diabetes Complicat 22:191-198. doi:10.1016/j. jdiacomp.2007.03.003 (Pubitemid 351545846)
16. Gutierrez JA et al (1997) Superoxide anions contribute to impaired regulation of blood pressure by nitric oxide during the development of cardiomyopathy. J Pharmacol Exp Ther 282: 1643-1649 (Pubitemid 27408351)
17. Rogus JJ et al (1998) Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension 31:627-631. http://hyper.ahajournals.org/cgi/content/full/31/2/627
18. Tomino Y et al (1999) Relationship between polymorphism in the angiotensinogen, angiotensin-converting enzyme or angiotensin II receptor and renal progression in Japanese NIDDM patients. Nephron 82:139-144. doi:10.1159/000045390 (Pubitemid 29263973)
19. Miura J et al (1999) Genetic polymorphism of renin-angiotensin system is not associated with diabetic vascular complications in Japanese subjects with long-term insulin dependent diabetes mellitus. Diabetes Res Clin Pract 45(1):41-49 (Pubitemid 29356123)
20. van Ittersum FJ et al (2000) Genetic polymorphisms of the renin-angiotensin system and complications of insulin-dependent diabetes mellitus. Nephrol Dial Transplant 15:1000-1007. doi: 10.1093/ndt/15.7.1000 (Pubitemid 30410372)
21. Fradin S et al (2002) Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab 28:27-32. doi:DM-02-2002-28-1-1262-3636-101019-ART4 (Pubitemid 34168747)
22. Chang HR et al (2003) Study of the polymorphism of angioten-sinogen, anigiotensin-converting enzyme and angiotensin receptor in type II diabetes with end-stage renal disease in Taiwan. J Chin Med Assoc 66:51-56
23. Prasad P et al (2006) Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet 7:42
24. Buraczynska M et al (2006) Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease. Nephrol Dial Transplant 21:979-983. doi:10.1093/ndt/gfk012
25. Mollsten A et al (2008) The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. J Diabetes Complicat 22:377-383. doi:10.1016/j.jdiacomp.2007. 06.005
26. Eroglu Z et al (2008) Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy. J Diabetes Complicat 22:186-190. doi:10.1016/j. jdiacomp.2006.12.004 (Pubitemid 351539058)
27. Tien KJ et al (2009) Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol 29:299-308. doi:10.1159/000163592
28. Ahluwalia TS et al (2009) ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy. DNA Cell Biol 28:141-150. doi:10.1089/dna. 2008.0810
29. Osawa N et al (2007) Combinational effect of genes for the renin-angiotensin system in conferring susceptibility to diabetic nephropathy. J Hum Genet 52:143-151. doi:10.1007/s10038-006-0090-5 (Pubitemid 46185108)
30. Zychma MJ et al (2000) Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropa-thy in type II diabetes. Nephrol Dial Transplant 15:1965-1970. doi:10.1093/ndt/15.12.1965
31. Zintzaras E, Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634-645. doi:10.1016/j.jclinepi. 2007.12.011 (Pubitemid 351766746)
32. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558. doi:10.1002/sim.1186 (Pubitemid 34746062)
33. Egger M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 (Pubitemid 27387172)
34. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
35. Zintzaras E, Papathanasiou AA, Stefanidis I (2009) Endothelial nitric oxide synthase gene polymorphisms and diabetic nephrop-athy: a HuGE review and meta-analysis. Genet Med 11:695-706. doi:10.1097/GIM.0b013e3181b2046b
36. Harrison-Bernard LM (2009) The renal renin-angiotensin system. Adv Physiol Educ 33:270-274. doi:10.1152/advan.00049.2009
37. Zhou JB et al (2010) Angiotensin-converting enzyme gene polymorphism is associated with type 2 diabetes: a meta-analysis. Mol Biol Rep 37:67-73. doi:10.1007/s11033-009-9648-6
38. Anderson PW, Do YS, WA (1993) Hsueh, Angiotensin II causes mesangial cell hypertrophy. Hypertension 21:29-35. http://hyper. ahajournals.org (Pubitemid 23006449)
39. Yip JW et al (1996) Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 45:1729-1733 (Pubitemid 26398952)
40. Feldt-Rasmussen B, Borch-Johnsen K, Mathiesen ER (1985) Hypertension in diabetes as related to nephropathy Early blood pressure changes. Hypertension 7:II18-II20
41. Thomas W et al (2001) Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the diabetes control and complications trial. J Am Soc Nephrol 12:333-340 (Pubitemid 32116375)
42. Reyes-Engel A et al (2006) Influence of gender and genetic variability on plasma angiotensin peptides. J Renin Angiotensin Aldosterone Syst 7:92-97. doi:10.3317/jraas.2006.015 (Pubitemid 44383503)
43. Hadjadj S et al (2001) Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: a prospective study. J Am Soc Nephrol 12: 541-549 (Pubitemid 32180023)
44. Curnow KM et al (1995) Alternatively spliced human type 1 angiotensin II receptor mRNAs are translated at different efficiencies and encode two receptor isoforms. Mol Endocrinol 9:1250-1262. doi:10.1210/me.9.9.1250
45. Bonnardeaux A et al (1994) Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69. http://hyper.ahajournals.org (Pubitemid 24195405)
46. Buraczynska M et al (2002) Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes. Pol Arch Med Wewn 108:725-730
47. Buraczynska M et al (2002) Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease. Nephron 92:51-55. doi: 10.1159/000064455 (Pubitemid 34983875)
48. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89-93 (Pubitemid 14084080)
49. Kagami S et al (1994) Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437. doi:10.1172/JCI117251 (Pubitemid 24177156)
50. Egger M et al (1997) Language bias in randomised controlled trials published in English and German. Lancet 350:326-329. doi: 10.1016/S0140-6736(97) 02419-7 (Pubitemid 27351115)
51. Passaro A et al (2003) Effect of metabolic control on homocys-teine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med 254:264-271. doi:10.1046/j.1365-2796.2003.01 184.x (Pubitemid 37070228)
52. Ma J et al (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102. http://cancerres.aacrjournals.org/content/57/6/1098#related-urls (Pubitemid 27138608)